Neonatal screening for cystic fibrosis
| The first 150 words of the full text of this article appear below. |
Birth prevalence
- Approximately 1 in 2500 live births in populations of Western European origin; similar prevalence in Jewish populations.
General characteristics
- Inheritance is autosomal recessive.
- One in 25 people is a carrier.
- More than 850 cystic fibrosis (CF) gene mutations have been identified; four mutations account for about 85% of the total.1
- Incidence of different mutations varies according to ethnic composition of populations.
Natural history
- 10-15% of newborns with CF require abdominal surgery to remove intestinal meconium plugs.
- Abnormal mucus secretion leads to chronic progressive lung damage.
- Intense respiratory management by inhalants, antibiotics, and physical therapy improves survival.
- Intestinal absorption of dietary protein and fat is impaired by a lack of pancreatic enzymes.
- Lung damage from cystic fibrosis leads to it being the main indication for heart-lung transplants.
- Expectation of life about 30 years.2 3
Screening procedure
- In newborns, radioimmunoassay for immunoreactive trypsin (IRT) on dried blood spots.4 False positive rate is dependent on the cut-off
. . . [Full text of this article]
Relevant Article
-
Rapid responses
Arch. Dis. Child. 2001 85: 72.[Extract] [Full Text]
eLetters:
Read all eLetters
- Neonatal Screening for Cystic Fibrosis
- Adam Jaffe
- ADC Online, 16 May 2001 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



